Health
How PCSK9 Controls Cholesterol—and Why It Matters
PCSK9, a protein discovered in 2003, determines how much 'bad' cholesterol stays in your blood by destroying the very receptors that clear it away. Un...
We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
24 articles with this tag
Health
PCSK9, a protein discovered in 2003, determines how much 'bad' cholesterol stays in your blood by destroying the very receptors that clear it away. Un...
Health
GLP-1 receptor agonists like semaglutide mimic a gut hormone to curb appetite and lower blood sugar, but emerging research shows they may also protect...
Health
Baxdrostat shows breakthrough results for resistant hypertension in Phase 3 trials, while the Galleri multi-cancer blood test detects over 50 cancer t...
Health
Resistant hypertension affects millions whose blood pressure stays dangerously high despite three or more medications. New research points to hidden h...
Health
A landmark 20-year analysis of over 14 million U.S. cardiovascular deaths reveals cold weather causes roughly 40,000 excess heart-related deaths annua...
Health
Erythritol is a zero-calorie sugar substitute found in thousands of keto and diet products. Growing research links it to blood clots, stroke risk, and...
Health
Sarcopenic obesity combines excess body fat with declining muscle mass, creating a vicious cycle that raises mortality risk by up to 83%. Here is how...
Health
Cold temperatures trigger vasoconstriction, thicken the blood, and spike blood pressure — a cascade that kills roughly 40,000 Americans a year. Here i...
Health
A major study of nearly 250,000 U.S. adults presented at the American College of Cardiology found that the shingles vaccine reduced serious cardiac ev...
Science
Scientists have identified a brainstem region called the lateral parafacial area that drives high blood pressure by constricting blood vessels, openin...
Science
As men age, their blood cells increasingly shed the Y chromosome in a process called mosaic loss of Y (mLOY), which scientists now link to heart disea...
Health
Merck's experimental oral PCSK9 inhibitor enlicitide slashed LDL cholesterol by up to 60% in a phase 3 trial of nearly 3,000 patients, matching inject...
Enable notifications and we'll let you know when something new is published.